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AbstrAct
Objectives The objective was to assess differences in 
healthcare costs within 180 days after discharge from 
open heart valve surgery in an intervention group receiving 
early, individualised and intensified follow- up compared 
with a historical control group.
Methods A cost- minimisation analysis comparing 
costs from a consecutive prospective cohort compared 
with a propensity matched cohort. Costs related to the 
intervention, hospital (outpatient visits and readmissions) 
and general practitioners (all contacts) were included. Data 
were obtained from electronic patient records and registry 
data. A logistic propensity model was used to identify the 
historical control group. Main results are presented as 
mean differences and 95% CIs based on bootstrapping.
Results After matching, the analysis included 300 
patients from the intervention group and 580 controls. The 
mean intervention cost was €171 (SD 79) per patient. 
After 180 days, the mean healthcare costs were €1284 
(SD 2567) for the intervention group and €2077 (SD 4773) 
for the controls. The cost of the intervention group was 
€793 (p<0.001) less per patient. The cost differences 
were explained mainly by fewer readmissions, fewer 
overall emergency visits and fewer contacts to the general 
practitioner during out- of- hours in the intervention group.
Conclusions The intervention consisting of early, 
individualised and intensified follow- up after open heart 
valve surgery significantly reduced the healthcare costs 
within 180 days after discharge.
BaCkgROund
Valvular heart disease constitutes a growing 
healthcare problem with a general preva-
lence of 2%–5% and a prevalence of 13% 
after the age of 75 years.1 2 Heart valve 
surgery can be a lifesaving procedure for 
patients with severe symptomatic heart valve 
disease.1 Nevertheless, following the surgery, 
up to 27% of patients may require readmis-
sion within 30 days after discharge.3–6 Besides 
readmissions related to complications such 
as atrial fibrillation, pericardial and pleural 
effusions, patients may also be readmitted 
due to unspecified symptoms without an 
obvious underlying cause.5 7 Thus, compli-
cations and readmissions after discharge can 
disrupt the recovery process of the patient 
with risk of delaying the physical and mental 
recovery.7 Additionally, readmissions are a 
general burden to the healthcare system as 
they increase the overall healthcare costs as 
seen by Tripathi et al.8
Only a few studies have investigated inter-
ventions aimed at reducing readmissions 
after open heart valve surgery.5 9 Lie et al have 
suggested that an intervention consisting 
of 24/7 telephone support might reduce 
readmissions by supporting patients to self- 
manage non- urgent symptoms at home.9 
In the Individualised follow- up after valve 
surgery (INVOLVE) study, we have recently 
demonstrated a reduction in readmissions 
among patients undergoing open heart valve 
surgery.5 The intervention consisted of early, 
individualised and intensified follow- up in a 
designated heart valve clinic after discharge 
to manage symptoms, prevent worsening of 
Key questions
What is already known about this subject?
 ► Readmissions after open heart valve surgery are 
costly, but data on costs of interventions to reduce 
readmissions are lacking.
What does this study add?
 ► Early, individualised follow- up after open heart 
valve surgery can reduce overall healthcare costs. 
Differences were explained by fewer readmissions, 
emergency visits and contacts to the general practi-
tioner during out- of- hours.
How might this impact on clinical practice?
 ► Similar interventions to reduce readmissions after 
open heart valve surgery should be implemented as 
it reduces overall healthcare costs and improves the 
clinical pathway after discharge.
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complications and provide support for the patient.5 Even 
though reducing readmissions improve care and may 
reduce costs, the effort to avoid readmissions may intro-
duce new costs. Accordingly, the current study is a cost- 
minimisation analysis of the intervention compared with 
usual care, conducted from a healthcare perspective.
The objective was to assess differences in patient health-
care costs within 180 days after discharge from open heart 
valve surgery in an intervention group receiving early, 
individualised and intensified follow- up compared with a 
propensity matched historical control group.
MateRials and MetHOds
study design and scope
Study design, participants and intervention in the 
INVOLVE study have previously been described.5 In brief, 
the study was a prospective cohort study investigating the 
effect of an individualised follow- up programme after 
open heart valve surgery on a composite endpoint of 
the first event of unplanned, cardiac hospital readmis-
sions or all- cause mortality within 180 days of discharge, 
compared with a historical control group. The primary 
analysis demonstrated that the reduction in the composite 
measure was driven by a reduction in readmission rates, 
while mortality rates were unaffected.5
This analysis focuses on the 180 days postdischarge 
cost of intervention, hospital and general practitioners 
services. As the intervention aimed at cardiac causes only, 
non- cardiac readmissions were not included. Data from 
general practitioners services were included in the cost- 
analyses as the intervention might affect how often the 
patients contact general practitioners postdischarge. Most 
commonly, the out- of- hours service includes both avoid-
able contacts and unavoidable contacts. For example, 
contacts from patients developing atrial fibrillation at 
home require an unavoidable contact, whereas symptom 
management related to the sternal wound, doubt about 
medication, precautions and symptom management, in 
general, could be avoidable contacts. These data were 
included to investigate possible changes during the inter-
vention period. Use of other healthcare services such as 
other primary care specialists, medication and munic-
ipal were not affected during the intervention and thus 
assumed to be similar.
Participants, setting and recruitment
From November 2016 to November 2017, consecutive 
patients were enrolled in the intervention at Odense 
University Hospital, Denmark. The historical popula-
tion was identified through the Western Denmark Heart 
Registry10 as patients undergoing surgery from August 
2013 to July 2016. Patients with one of the following 
surgical procedure codes were included (Nordic/
NOMESCO Classification of Surgical Procedures11: Aorta 
(KFCA, KFMA, KFMC, KFMD), Mitral (KFKB, KFKC, 
KFKD, KDKW) and Tricuspidal (KFGC, KFGE).
Exclusion criteria were infective endocarditis, transfer 
to neurological rehabilitation from the surgical ward, 
transcatheter aortic valve procedures and living outside 
the hospital’s catchment area at inclusion.
intervention and control
Patients in both groups were referred to their general 
practitioner for removal of stitches 7–10 days after 
surgery, underwent an echocardiography 4–6 weeks 
after surgery as recommended by the European guide-
lines1 and were encouraged to participate in cardiac 
rehabilitation.
Intervention
The patients were included prior to surgery by a nurse, 
and the intervention began at discharge. The key compo-
nent of the intervention was an individual risk assess-
ment, multidisciplinary conducted. This was based on a 
clinical examination performed by a nurse, including a 
bedside focused chest ultrasound to assess pleural and 
pericardial effusion and a frailty test.5 12 13 The results 
of the clinical examination were discussed with a cardi-
ologist, who further screened the ECG and evaluated 
the medical treatment. All information was evaluated 
and summarised in an individual risk assessment with 
patients being grouped into a presumed high, interme-
diate or low risk of readmission. A further central part of 
the intervention was patient education performed by the 
nurse before discharge.
The follow- up programme was determined by the 
patients’ risk profile, as previously outlined.14 The 
intervention lasted for 4 weeks after discharge, and 
patients were seen according to their risk profile. 
Thus, patients being at high risk of readmission 
received a closer follow- up compared with patients 
being at intermediate or low risk of readmission. The 
specific elements of the follow- up after discharge 
included telephone and outpatient consultations. 
All consultations aimed at physical and mental symp-
toms, possible effusion scans, patient education and a 
plan for further follow- up.
Control group
Follow- up of the control group consisted of routine 
discharge directly to the home or a local hospital and a 
short, unstructured telephone consultation within 7 days 
postdischarge performed by the nurses from the surgical 
ward. After discharge, the general practitioner was the 
primary care person.
data collection
Demographic and clinical data, baseline
Demographics and clinical characteristics at baseline 
and during index admission were obtained from elec-
tronic medical records and the Western Denmark Heart 
Registry.10
Follow-up after discharge
Visits in outpatient clinics were captured from elec-
tronic medical records. Contact causes and whether the 
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Table 1 Resource use per patient in the intervention
The risk assessment groups of the intervention Total 
intervention
(n=300)
High risk
(n=96)
Intermediate risk
(n=174)
Low risk
(n=30)
Staff time to risk assessment (minutes)*, mean (SD)
  Nurse – – – 41.3 (5.1)*
  Cardiologist – – – 5.1 (1.9)*
  Secretary – – – 10 (0.5)*
Telephone consultations, mean (SD)
Average number of consultations
  Initiated by nurse 1.3 (1.3) 1.3 (1.0) 1.1 (0.9) 1.3 (1.1)
  Initiated by the patient 0.6 (1.1) 0.4 (0.7) 0.6 (1.4) 0.5 (1.0)
Duration of consultations, all (minutes)*† – – – 13.3 (3.7)*
Nurse outpatient consultation, mean (SD)
  Average number of consultations, per patient 2.5 (1.8)‡ 1.9 (1.2) 1.3 (1.3)‡ 2.1 (1.5)
  Duration of consultations, all (minutes)* – – – 30.2 (3.6)*
*The duration was recorded in minutes for the first 50 patients.
†Duration (minutes) of telephone consultations initiated by patients was not registered separately (but assumed to be equal to telephone 
consultations initiated by nurses).
‡Denotes statistically significant difference from intermediate- risk group ascertained by t- test.
consultation was with a nurse or a physician were regis-
tered. Information on the duration of consultations 
(time used for staff) was recorded in minutes for the first 
50 patients, and the observed mean time was assumed for 
all patients. The time duration of other types of consulta-
tions (eg, heart failure, arrhythmia) was based on expert 
assessment.
Readmissions
Readmissions were defined as an overnight hospital 
stay more than 24 hours after discharge from the index 
admission due to either a cause related to the surgery or 
a cardiac cause as described elsewhere.5
General practitioner
Contacts with general practitioners (both during normal 
opening hours and out- of- hours consultations) after 
discharge were obtained from The Danish National 
Health Service Register.15
Cost data
Unit costs were based on detailed cost calculations 
done in collaboration with the financial department at 
the hospital. Costs in general practice were obtained as 
fee reimbursement from The Danish National Health 
Service Register, adjusted to 2018- price level. The costs 
are presented as 2018-€ (7.46 DKK=1 €).
Costs of the intervention, staff time
Costs of the intervention included staff time spent on 
discharge examination (preparation time, effusion scans, 
frailty score, patient education and risk assessment), 
outpatient and telephone consultations (tables 1 and 2). 
Costs of the intervention were registered according to the 
risk groups.
Costs of the hospital services
Costs of hospital- based contacts (hospitalisations, outpa-
tient visits and emergency visits) were based on existing 
unit costs (table 2). The costs of staff salaries were esti-
mated based on actual working hours and duration of 
consultations (adjusted to the actual time per patient) 
(see online supplementary material S1).
Furthermore, information from electronic medical 
records regarding echocardiography, thoracocentesis or 
pericardiocentesis was registered, and unit costs calcu-
lated (see online supplementary material S1).
The cost per hospital bed day (€274) was assumed as 
the marginal cost of readmissions days. The marginal cost 
of the intensive care unit (ICU) bed days was assumed 
at €1369. The costs of a bed day included costs of staff 
salary, food, medication and overhead (hospital building 
operation, equipment and maintenance). In the unit 
costs of specific outpatient procedures, staff cost was 
added separately.
The cost of an emergency visit due to cardiac causes 
including echocardiography corresponded to 0.5 hospital 
bed day = €137 as suggested by the financial department 
(table 2).
Costs of contacts to general practitioners
Resource use and costs were coded into the following 
groups: face- to- face or telephone consultations, other 
costs related to the contact and out- of- hours consulta-
tions (table 2).
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Table 2 Unit costs of resources related to the intervention, 
hospital and general practitioner services
Unit cost (2018-€)
Intervention*
  Risk assessment 46
  Telephone consultation 16
  Outpatient consultation 48
Readmissions
  Hospital bed day 274
  ICU- bed day 1369
  Procedures performed during readmissions
   Thoracentesis 134
   Pericardiocentesis, parasternal approach 129
   Pericardiocentesis, subxiphoid, surgical 10 752
Emergency visits 137
Outpatient procedures/consultations
  Echocardiography 65
  Thoracentesis 238
  Pericardiocentesis, parasternal approach 344
  Heart failure consultations
   Consultation with nurse 35
   Consultation with cardiologist 66
  Arrhythmia consultations
   Consultation with nurse 27
   Consultation with cardiologist 61
  Unspecified cardiology consultations
   Consultation with nurse 35
   Consultation with cardiologist 61
  Cardiac Surgery consultations 61
Consultations with general practitioner†
  Direct/in- person, normal opening hours 18
  Telephone, normal opening hours 4
  Out- of- hours contacts, all 19
*Based on hourly salary and multiplied with actual time used.
†Other costs related to the consultations are calculated for each 
patient and added to the analyses.
ICU, intensive care unit.
ethics
The study was approved by the Danish Data Protection 
Agency (18/19152), Danish Patient Safety Authority and 
conformed with the principles outlined in the Declara-
tion of Helsinki.16 The study was registered at  Clinical-
Trials. gov (NCT03053778).
statistical analyses
A propensity score matching was performed as described 
by Rosenbaum and Rubin.17 The multiple logistic 
propensity model included sex, age, acute/unplanned 
surgery, primary diagnosis, type of surgery, concomitant 
coronary artery bypass surgery, obstructive or restrictive 
lung disease, preoperative New York Heart Association 
class, EuroScore II (logistic), estimated preoperative 
glomerular filtration rate, permanent pacemaker prior 
to surgery, atrial fibrillation and body mass index. These 
covariates were chosen as variables assumed to be related 
to outcome, as suggested by Thoemmes and Kim.18 The 
actual matching process was performed as a 1:2 (1 inter-
vention:2 controls) nearest- neighbour matching without 
replacement and a calliper width of 0.2 SD5 19 The 
matching process and group balance were validated with 
descriptive statistics.
Continuous data were presented as mean and SD; cate-
gorical variables as frequencies and percentages.
Differences in healthcare utilisation were tested with 
the χ2- test. Associations between mean contacts among 
groups were assessed with Poisson regression and 
expressed with a p value.
The cost data were, as expected, positively skewed.20 
Therefore, between- group differences were reported as 
95% CIs based on non- parametric bootstrapping (5000 
replicates).21 In addition, an analysis of the differences in 
costs of the overall unmatched population and interven-
tion group was performed as a sensitivity analysis.
A p value below 0.05 was considered statistically signifi-
cant. SPSS 24 (IBM, Armonk, New York, USA) and Stata 
13 (Stata, College Station, Texas, USA) were used to 
conduct the statistical analyses.
Results
In total, 308 patients undergoing open heart valve 
surgery were included in the prospective study and 980 
patients comprised the historical cohort. After propen-
sity matching, 300 patients in the intervention group 
were matched to 580 historical patients (in the following 
mentioned as the historical control group). The matching 
process successfully reduced the variation between the 
intervention and the historical control group, creating 
two well- balanced groups (see online supplementary 
material S2). During the intervention period, aortic valve 
repair was introduced as a surgical option for younger 
patients with aortic regurgitation. Due to this, eight 
patients (2%), where aortic valve repair was performed, 
could not be matched with historical controls and were 
excluded from further analyses. All 300 patients in the 
intervention group underwent in- hospital risk assessment 
and individualised follow- up.
differences in resource use
Resource use related to the intervention was divided into 
resources related to the risk assessment at discharge, 
telephone consultations and outpatient consultations 
(table 1). The results reflect the intervention with 
patients considered being at high risk receiving more 
consultations compared with patients in the intermediate 
or low- risk group. There were few significant differences 
in mean resource use among patients in the different risk 
assessment groups (see online supplementary material 
S3).
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Table 3 Resource use within 180 days after discharge
Resource
Intervention group (n=300) Historical 
control 
group 
(n=580) P value*
High risk
(n=96)
Intermediate 
risk
(n=174)
Low risk
(n=30)
Total 
intervention 
group
Cardiac readmissions, n (%)†
  Unplanned cardiac readmissions 29 (30) 36 (21) ≤3 68 (23) 219 (38) <0.001
  Planned cardiac readmissions 5 (5) 5 (2) ≤3 11 (4) 31 (5) 0.268
  Readmission with pericardiocentesis‡ 5 (5) ≤3 ≤3 9 (3) 40 (7) 0.020
  Thoracentesis ≤3 ≤3 ≤3 5 (2) 18 (3) 0.205
Emergency room visits, n (%)† 9 (9) 16 (9) ≤3 28 (9) 75 (13) 0.116
Outpatient consultations/procedures, n (%)†
  Echocardiography 88 (92) 168 (97) 30 (100) 286 (95) 528 (91) 0.022
  Pericardiocentesis 10 (10)§ 6 (3) ≤3 17 (6) 0 (0) <0.001
  Thoracentesis 9 (9) 8 (5) ≤3 17 (6) 31 (5) 0.842
  Heart failure consultations 8 (8) 14 (8) ≤3 24 (8) 54 (9) 0.517
  Arrhythmia consultations 18 (19) 28 (16) 5 (17) 51 (17) 70 (12) 0.044
  Other (unspecified) cardiology consultations 17 (18) 36 (21) ≤3 60 (20) 209 (36) <0.001
  Cardiac surgery consultations 7 (7) 7 (4) ≤3 17 (6) 34 (6) 0.906
General practitioner, n (%)†
  Direct consultations, normal opening hours 92 (96) 170 (98) 30 (100) 292 (97) 559 (96) 0.452
  Telephone consultations, normal opening hours 78 (81) 133 (76) 25 (83) 236 (79) 503 (87) 0.002
  Out- of- hours consultations, all 29 (30) 43 (25) 9 (30) 81 (27) 220 (38) 0.001
*P<0.05, differences between the intervention group and the historical control group, compared using χ2.
†N and %=number and proportion of patients with one or more readmission/consultation/procedure.
‡Both parasternal and subxiphoid approach.
§Denotes statistically significant difference from intermediate- risk group ascertained by χ2.
Compared with the historical control group, fewer 
patients in the intervention group experienced a read-
mission (23% vs 37%, p<0.001) and they were fewer days 
readmitted (mean days 1.66 (SD 5.43) vs 3.85 (SD 10.73), 
p<0.001). However, there was no difference in the dura-
tion of individual readmission among readmitted patients 
(table 3 and see online supplementary material S3). 
Patients in the intervention group had fewer readmis-
sions due to pericardial effusions (3% vs 7%, p=0.018), 
which was driven by 17 patients (6%) in the intervention 
group who underwent pericardiocentesis in the outpa-
tient heart valve clinic. Of those, five patients were also 
readmitted due to pericardial effusion. Thus, the overall 
number of patients undergoing pericardiocentesis after 
discharge was unchanged (21 patients (7%) in the inter-
vention group vs 40 (7%) in the historical control group, 
p=0.889). Pericardiocentesis as an outpatient procedure 
was only performed during the intervention period.
Specific outpatient consultations varied between the 
intervention and the historical control group. Although 
the vast majority underwent follow- up echocardiography 
according to guidelines in both groups, it was performed 
as an outpatient procedure for more patients in the inter-
vention group (95% vs 91%, p=0.022). Echocardiography 
was performed during readmission in the remaining 
patients in the intervention group, where all patients had 
control echocardiography performed. Whether this also 
was the case in the control group, although likely, cannot 
be confirmed by the dataset. During the intervention 
period, more patients had consultations due to a rhythm 
disorder (17% vs 12%, p=0.044), while more patients in 
the historical control group had outpatient consultations 
without specific causes (36% vs 20% in the intervention 
group, p<0.001) (table 3 and see online supplementary 
material S3).
The proportion of patients with contacts to general 
practitioners and visits to the emergency department 
were similar in the two groups, except that telephone 
consultations (79% vs 87%, p=0.002) and out- of- hour 
contacts to general practitioner (27% vs 38%, p=0.001) 
were less frequent in the intervention group.
differences in costs
The mean cost of the intervention was estimated at €171 
(SD 79) per patient. The overall 180 day healthcare costs 
per patient were €1284 (SD 2567) for the intervention 
group and €2077 (SD 4773) for the historical controls. 
The mean saving was €793 (p<0.001) per patient 
(table 4). The lower costs of the intervention group were 
caused by lower costs of cardiac readmissions, contacts to 
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Table 4 Cost of the intervention and 180 days healthcare costs per patient
Costs (2018-€)
Intervention group (n=300)
Historical 
control group 
(n=580)
Mean difference* 
(bootstrapped 95% CI)
Mean costs per patient (SD)
Mean costs 
per patient 
(SD)
High risk 
(n=96)
Intermediate 
risk (n=174)
Low risk 
(n=30)
Total 
intervention 
group
Intervention 194 (98) 165 (62) 137 (84) 171 (79) – 171 (162 to 180)
Cardiac readmissions 630 (2021) 736 (2930) 82 (251) 637 (2512) 1540 (4692) −903 (−1385 to −421)
Emergency room visits 14 (47) 13 (40) 14 (42) 13 (42) 21 (58) −8 (−14 to −1)
Outpatient consultations 212 (189) 165 (159) 168 (203) 181 (174) 178 (149) 2 (−21 to 25)
General practitioner 278 (212) 283 (226) 289 (230) 282 (221) 337 (247) −55 (−88 to −24)
Total costs 1328 (2106) 1362 (2975) 690 (463) 1284 (3028) 2077 (4773) −793 (−1279 to −306)
*Comparison of mean costs per patient in the total intervention and control group, reported as mean differences and 95% CI based on non- 
parametric bootstrap (5000 bootstraps).
general practice and emergency visits. Costs of outpatient 
consultations were similar for the two groups. The sensi-
tivity analysis for the differences in costs of the overall 
unmatched population demonstrated a mean difference 
of €826 (p<0.001) per patient (online supplementary 
material S4).
disCussiOn
In this study, we investigated differences in direct patient- 
related healthcare costs in the early period after heart 
valve surgery between patients offered early, individual-
ised and intensified follow- up and a propensity matched 
historical control group. We found that the overall cost 
for the intervention group was significantly lower than 
that for the historical control group and that the addi-
tional intervention cost was outbalanced by the saving in 
readmissions, overall contacts with general practice and 
emergency visits.
This study is, to our knowledge, the first to investigate 
the costs of an intervention aimed at reducing readmis-
sions after open heart valve surgery. The existing studies 
on costs and readmissions after heart valve procedures 
tend to focus on different aspects: Tripathi et al investi-
gated differences in the costs of readmissions related to 
the surgery and compared costs between patients under-
going surgical aortic valve replacements with patients 
undergoing transcatheter aortic valve replacements 
(TAVR). The study was based on a national database 
and included n=4682 patients.8 Also, based on the same 
national readmission database from the US, Kolte et al 
have investigated the costs of readmission, but focusing 
on TAVR- patients (n=12 221) alone.22 Thus, the cost 
estimates from these studies are therefore not compa-
rable with our cost estimates, which includes patients 
undergoing open heart valve surgery—based on clin-
ical data from electronic patient records combined with 
register- based data. However, as demonstrated by Kolte 
et al, readmissions after TAVR are commonly related 
to postprocedure complications, why they suggest that 
interventions should be aimed at high- risk patients. This 
finding supports the need for the current intervention in 
the INVOLVE study. We have demonstrated how aware-
ness of complications in combination with early and indi-
vidualised follow- up can reduce readmissions after open 
heart valve surgery.5 In combination, similar interven-
tions might be appropriate among patients undergoing 
TAVR, as suggested by Kolte.22
In our study, the costs of readmissions comprise the 
highest proportion of the total costs, followed by contacts 
to the general practitioner. All patients were referred to 
their general practitioner for removal of stitches. There-
fore, most patients had at least one contact with general 
practitioners. However, the intervention group had 
significantly fewer telephone consultations and out- of- 
hour contacts to general practitioners compared with the 
historical control group. It has previously been demon-
strated how patients undergoing heart valve surgery feel 
insecure and worry in the early period after discharge.23 
The additional telephone consultations and out- of- hours 
services in the historical control group might be related 
to such concerns. During the intervention, patients had 
regular contacts to a nurse in the heart valve clinic, and 
they had the possibility of contacting the nurse, whenever 
needed. We suggest that this easy access to the heart valve 
clinic partly explain the lower frequency of general prac-
titioner out- of- hours consultations.
Another finding in our study is the cost- saving related 
to introducing pericardiocentesis as an outpatient proce-
dure in the intervention group. All patients in the inter-
vention group had a focused chest ultrasound performed 
at discharge as part of the intervention, and patients with 
more than trivial pericardial effusions were managed in 
the early outpatient setting and seen within the first week 
after discharge as suggested in guidelines.24 Pericardio-
centesis was performed before the patients developed 
tamponade, driven by imaging with significant effusion 
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and clinical symptoms.24 When compared with the histor-
ical control group, the proportion of patients needing 
pericardiocentesis were similar, although the clinical 
pathway and the costs varied greatly.
Unexpectedly, the costs of outpatient consultations 
were not significantly different between patients receiving 
the intervention and patients in the historical cohort. We 
had expected that the introduction of the intervention 
would be associated with an increase in outpatient consul-
tations, but this was not the case. This may relate to an 
optimised clinical pathway introduced as a further result 
of the intervention, as the nurses in the outpatient clinic 
ensured the pathway to include consultations related to 
specific clinical problems. In addition, echocardiography 
was performed by specialised cardiologists during the 
intervention period. Consequently, during the interven-
tion, consultations without a specific cause were reduced 
while consultations due to rhythm disorders increased. 
In general, the multidisciplinary approach to patients 
undergoing heart valve surgery is known to both optimise 
the clinical pathway and be cost- effective.25 26
Despite the significant saving introduced by the 
intervention, there is still potential for further opti-
misation of the clinical pathway after discharge, as 
patients still receive many contacts with healthcare 
professionals across different sectors, and although 
the readmission rates were reduced, they remain high. 
When investigating aspects of further optimisation of 
the clinical pathway after open heart valve surgery, the 
infrastructure in primary care and community services 
play an important role.27 In Denmark, the primary 
healthcare system commonly includes general practi-
tioners after open heart valve surgery, which is high-
lighted by the high numbers of contacts with general 
practitioners in the postdischarge period. This knowl-
edge should be incorporated into future studies. 
Similarly, the generalisability of the current study 
might only be relevant in similar healthcare systems; 
therefore, local audits of complications and patterns 
of readmission are appropriate before conducting a 
similar study or changing practise.27
strengths and limitations
A key strength of the study was the consecutive inclu-
sion of patients with access to complete data from 
electronic patient records on all patients. These data 
were combined with register- based information on 
contacts with general practitioners. In addition, infor-
mation on costings was primarily based on individual- 
level detailed microcosting and not a macrocosting 
approach (general valuation).
The study has some limitations. First, a key limitation 
is the non- randomised design of the study. Although 
we performed propensity matching to minimise bias in 
causal inferences, the results should still be interpreted 
in the context of this design. To support the reported 
analyses, the sensitivity analysis of the overall unmatched 
population demonstrated a similar cost difference among 
the two groups which suggests that the matching process 
did not exclude patients with, particularly high or low 
costs compared with the propensity matched population.
Second, the study was performed as a single- centre 
study and testing of the intervention in another clinical 
setting would strengthen the findings. Third, during read-
missions, costings of time spent in ICU were included, 
but costs of reoperation or procedures other than peri-
cardiocentesis were not. This means that due to more 
readmissions in the control group and therefore maybe 
more reoperations, the costs of the control group might 
be underestimated.
In conclusion, we found that the early, individualised 
and intensified follow- up after open heart valve surgery 
significantly reduced the costs within 180 days after 
discharge. The reduction was caused by fewer readmis-
sions, fewer emergency visits and fewer contacts to the 
general practitioner during out- of- hours.
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